![Liana Patt](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Liana Patt
Amministratore Delegato presso Integra Holdings Ltd.
Profilo
Liana Patt is currently the Chief Executive Officer at Integra Holdings Ltd.
and FutuRx Ltd.
She is also a Director at Lipomedix Pharmaceuticals Ltd., Ayana Pharma Ltd., GliXogen Therapeutics Ltd., and HighRAD Ltd.
Previously, she worked as a Director at Atox Bio Ltd.
and as the Vice President-Global Business Development at Teva Pharmaceutical Industries Ltd.
Dr. Patt received her undergraduate degree from Tel-Aviv University, her doctorate from Weizmann Institute of Science, and her MBA from Edinburgh Business School.
Posizioni attive di Liana Patt
Società | Posizione | Inizio |
---|---|---|
Integra Holdings Ltd.
![]() Integra Holdings Ltd. MiscellaneousMiscellaneous Integra Holdings Ltd. operates as a holding company. It invests in the pharmaceutical industry. The company was founded in 2012 and is headquartered in Jerusalem, Israel. | Amministratore Delegato | - |
Lipomedix Pharmaceuticals Ltd.
![]() Lipomedix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Lipomedix Pharmaceuticals Ltd. engages in the development of cancer therapy based on liposome delivery. It offers Promitil®, a proprietary formulation of a lipid-based pro-drug of MMC (MLP) which enables efficient delivery and release of active MMC to tumors in vivo. The company was founded by Alberto Gabizon and Rami Kremien and is headquartered in Jerusalem, Israel. | Direttore/Membro del Consiglio | - |
HighRAD Ltd.
![]() HighRAD Ltd. Information Technology ServicesTechnology Services HighRAD Ltd. provides intelligent computer assessment support solutions. The company is based in Tel Aviv, Israel. Yossi Srour has been the CEO of the Israeli company since 2019. | Direttore/Membro del Consiglio | - |
Glixogen Therapeutics Ltd.
![]() Glixogen Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Glixogen Therapeutics Ltd. engages in the development of treatment to enhance remyelination in neurodegenerative disorders. The company was founded on October 11, 2018 and is headquartered in Ness Ziona, Israel. | Direttore/Membro del Consiglio | 08/06/2022 |
Ayana Pharma Ltd.
![]() Ayana Pharma Ltd. Pharmaceuticals: MajorHealth Technology Ayana Pharma Ltd. is an Israeli pharmaceutical company that specializes in developing liposomal therapeutics for cancer treatment. The company is based in Jerusalem, Israel. Ayana Pharma was founded in 2012 by Yechezkel Barenholz and Avraham Molcho, with Yechezkel Barenholz serving as the CEO since its inception. | Direttore/Membro del Consiglio | - |
FutuRx Ltd.
![]() FutuRx Ltd. Investment ManagersFinance FutuRx Ltd (FutuRx ) is a venture capital firm founded in 2014. The firm is headquartered in Ness Ziona. | Amministratore Delegato | 01/05/2022 |
Precedenti posizioni note di Liana Patt
Società | Posizione | Fine |
---|---|---|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | - |
Atox Bio Ltd.
![]() Atox Bio Ltd. BiotechnologyHealth Technology Atox Bio, Inc. provides novel immune modulators for critically ill patients with severe infections. The firm discovers and develops novel immune modulators for critically ill patients with severe infections. Its main product is AB103, a novel immune modulator. The company was founded by Raymond Kaempfer and Gila Arad in 2003 and is headquartered in Ness Ziona, Israel. | Direttore/Membro del Consiglio | - |
Formazione di Liana Patt
Weizmann Institute of Science | Doctorate Degree |
Edinburgh Business School | Masters Business Admin |
Tel-Aviv University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
Aziende private | 7 |
---|---|
Atox Bio Ltd.
![]() Atox Bio Ltd. BiotechnologyHealth Technology Atox Bio, Inc. provides novel immune modulators for critically ill patients with severe infections. The firm discovers and develops novel immune modulators for critically ill patients with severe infections. Its main product is AB103, a novel immune modulator. The company was founded by Raymond Kaempfer and Gila Arad in 2003 and is headquartered in Ness Ziona, Israel. | Health Technology |
Integra Holdings Ltd.
![]() Integra Holdings Ltd. MiscellaneousMiscellaneous Integra Holdings Ltd. operates as a holding company. It invests in the pharmaceutical industry. The company was founded in 2012 and is headquartered in Jerusalem, Israel. | Miscellaneous |
Lipomedix Pharmaceuticals Ltd.
![]() Lipomedix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Lipomedix Pharmaceuticals Ltd. engages in the development of cancer therapy based on liposome delivery. It offers Promitil®, a proprietary formulation of a lipid-based pro-drug of MMC (MLP) which enables efficient delivery and release of active MMC to tumors in vivo. The company was founded by Alberto Gabizon and Rami Kremien and is headquartered in Jerusalem, Israel. | Health Technology |
HighRAD Ltd.
![]() HighRAD Ltd. Information Technology ServicesTechnology Services HighRAD Ltd. provides intelligent computer assessment support solutions. The company is based in Tel Aviv, Israel. Yossi Srour has been the CEO of the Israeli company since 2019. | Technology Services |
Glixogen Therapeutics Ltd.
![]() Glixogen Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Glixogen Therapeutics Ltd. engages in the development of treatment to enhance remyelination in neurodegenerative disorders. The company was founded on October 11, 2018 and is headquartered in Ness Ziona, Israel. | Commercial Services |
Ayana Pharma Ltd.
![]() Ayana Pharma Ltd. Pharmaceuticals: MajorHealth Technology Ayana Pharma Ltd. is an Israeli pharmaceutical company that specializes in developing liposomal therapeutics for cancer treatment. The company is based in Jerusalem, Israel. Ayana Pharma was founded in 2012 by Yechezkel Barenholz and Avraham Molcho, with Yechezkel Barenholz serving as the CEO since its inception. | Health Technology |
FutuRx Ltd.
![]() FutuRx Ltd. Investment ManagersFinance FutuRx Ltd (FutuRx ) is a venture capital firm founded in 2014. The firm is headquartered in Ness Ziona. | Finance |
- Borsa valori
- Insiders
- Liana Patt